129 related articles for article (PubMed ID: 3038939)
41. Transport capacity, alkaline phosphatase activity and protein content of glutaraldehyde-treated cell forms of Escherichia coli.
Gorman SP; Scott EM
Microbios; 1977; 19(77-78):205-12. PubMed ID: 30880
[TBL] [Abstract][Full Text] [Related]
42. Effect of formaldehyde, glutaraldehyde and sucrose on the tissue antigenicity.
Deng JS; Beutner EH
Int Arch Allergy Appl Immunol; 1974; 47(4):562-9. PubMed ID: 4213054
[No Abstract] [Full Text] [Related]
43. Preparation of a prototype inactivated hepatitis A virus vaccine from infected cell cultures.
Binn LN; Bancroft WH; Lemon SM; Marchwicki RH; LeDuc JW; Trahan CJ; Staley EC; Keenan CM
J Infect Dis; 1986 Apr; 153(4):749-56. PubMed ID: 3005435
[TBL] [Abstract][Full Text] [Related]
44. Parameters influencing the attachment of hepatitis A virus to a variety of continuous cell lines.
Zajac AJ; Amphlett EM; Rowlands DJ; Sangar DV
J Gen Virol; 1991 Jul; 72 ( Pt 7)():1667-75. PubMed ID: 1649900
[TBL] [Abstract][Full Text] [Related]
45. Effectiveness of a procedure for disinfecting the vaginal photoplethysmograph contaminated with herpes simplex virus type 2.
Morokoff PJ; Myers LS; Hay J; Flora MN
Arch Sex Behav; 1988 Aug; 17(4):363-9. PubMed ID: 2844137
[TBL] [Abstract][Full Text] [Related]
46. [Virucidal activity of the disinfectant "gigasept" against different enveloped and non-enveloped RNA-and DNA-viruses, pathogenic for men. I. Investigation in the suspension test (author's transl)].
Thraenhart O; Kuwert E
Zentralbl Bakteriol Orig B; 1975 Dec; 161(3):209-32. PubMed ID: 176845
[TBL] [Abstract][Full Text] [Related]
47. L-asparaginase bound to collagen membranes: effect of glutaraldehyde crosslinking on stabilization of catalytic activity.
Jefferies SR; LaPresto P; Bernath FR
J Biomed Mater Res; 1978 Jul; 12(4):491-503. PubMed ID: 98529
[TBL] [Abstract][Full Text] [Related]
48. Glutaraldehyde inactivation of enveloped DNA viruses in the preparation of haemoglobin-based oxygen carriers.
Ma H; Li Q; Feng K; Zhang Y; Zhu H; Chen C; Yan K
Artif Cells Nanomed Biotechnol; 2018 Feb; 46(1):33-38. PubMed ID: 29081252
[TBL] [Abstract][Full Text] [Related]
49. Inhibition of the expression of hepatitis A and B viruses (HAV and HBV) proteins by interferon in a human hepatocarcinoma cell line (PLC/PRF/5).
Berthillon P; Crance JM; Leveque F; Jouan A; Petit MA; Deloince R; Trepo C
J Hepatol; 1996 Jul; 25(1):15-9. PubMed ID: 8836896
[TBL] [Abstract][Full Text] [Related]
50. [The isolation and study of the characteristics of a cytopathic strain of the hepatitis A virus].
Maĭdaniuk AG; Tiunnikov GI; Konakova VE; Bondarenko EP; Nemtsov IuV; Karpovich LG; Kalashnikova TV; Mamaeva NV; Sosnovtsev SV; Chizhikov VE
Vopr Virusol; 1993; 38(3):101-5. PubMed ID: 8073747
[TBL] [Abstract][Full Text] [Related]
51. Inactivation of hepatitis A virus by heat treatment in aqueous solution.
Murphy P; Nowak T; Lemon SM; Hilfenhaus J
J Med Virol; 1993 Sep; 41(1):61-4. PubMed ID: 8228940
[TBL] [Abstract][Full Text] [Related]
52. A simplified multiwell plate assay for the measurement of hepatitis A virus infectivity.
Krah DL
Biologicals; 1991 Jul; 19(3):223-7. PubMed ID: 1659431
[TBL] [Abstract][Full Text] [Related]
53. Reactions of infectious mononucleosis sera with glutaraldehyde-treated human erythrocytes.
Wasik M; Milgrom F
Immunol Commun; 1984; 13(5):439-45. PubMed ID: 6440857
[TBL] [Abstract][Full Text] [Related]
54. Propagation of human hepatitis A virus in a hepatoma cell line.
Frösner GG; Deinhardt F; Scheid R; Gauss-Müller V; Holmes N; Messelberger V; Siegl G; Alexander JJ
Infection; 1979; 7(6):303-5. PubMed ID: 232698
[TBL] [Abstract][Full Text] [Related]
55. [Dynamics of the accumulation of virus particles with different physico-chemical properties in FRhK-4 cells infected with hepatitis A virus].
Kusov IuIu; Nastashenko TA; Kazachkov IuA; Panina LI
Mol Gen Mikrobiol Virusol; 1987 Jan; (1):26-32. PubMed ID: 3031492
[TBL] [Abstract][Full Text] [Related]
56. The hardness of bovine dentine after glutaraldehyde treatment.
Wemes JC; Arends J
Oral Surg Oral Med Oral Pathol; 1984 Dec; 58(6):722-4. PubMed ID: 6438573
[TBL] [Abstract][Full Text] [Related]
57. Properties of a hepatitis A virus candidate vaccine strain.
Heinricy U; Stierhof YD; Pfisterer M; Flehmig B
J Gen Virol; 1987 Sep; 68 ( Pt 9)():2487-93. PubMed ID: 2821186
[TBL] [Abstract][Full Text] [Related]
58. Studies on the actions of glutaraldehyde, formaldehyde, and mixtures of glutaraldehyde and formaldehyde on tissue proteins.
Kirkeby S; Moe D
Acta Histochem; 1986; 79(1):115-21. PubMed ID: 3090833
[TBL] [Abstract][Full Text] [Related]
59. Hapten-specific T lymphocyte activation by glutaraldehyde-treated macrophages: an argument against antigen processing by macrophages.
Thomas DW
J Immunol; 1978 Nov; 121(5):1760-6. PubMed ID: 152327
[TBL] [Abstract][Full Text] [Related]
60. T cell-mediated cytotoxicity against trinitrophenyl-modified cells: effect of glutaraldehyde treatment on the immunogenicity and antigenicity of trinitrophenyl-modified cells.
Forman J
J Immunol; 1977 May; 118(5):1755-62. PubMed ID: 404357
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
